Neovasc Inc. announced that its Tiara transcatheter mitral valve replacement (TMVR) device and its Neovasc Reducer device for the treatment of refractory angina were highlighted in presentations at the CSI Frankfurt 2019 conference, June 26-29, in Frankfurt, Germany.
